PULMONARY NEUROENDOCRINE TUMOR
Clinical trials for PULMONARY NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new PULMONARY NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for PULMONARY NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy could shrink rare lung tumors
Disease control Recruiting nowThis study tests whether adding chemotherapy to surufatinib works better than surufatinib alone for people with a rare lung cancer called pulmonary neuroendocrine tumor. About 96 adults will be randomly assigned to one of two treatment groups. The goal is to see if the combinatio…
Matched conditions: PULMONARY NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New PET scan agent aims to better detect rare tumors
Diagnosis Recruiting nowThis study tests a new radioactive imaging agent called 68Ga-HA-DOTATATE to see if it can safely and accurately detect neuroendocrine tumors using PET/CT scans. About 600 people with known or suspected tumors will receive the agent and be followed for one year. The goal is to imp…
Matched conditions: PULMONARY NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC